Get Live Data

If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. Total Voting Rights

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,799.50
Bid: 1,796.00
Ask: 1,796.50
Change: 19.00 (1.07%)
Spread: 0.50 (0.028%)
Open: 1,784.00
High: 1,799.50
Low: 1,780.00
Prev. Close: 1,780.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Mar 2024 15:00

RNS Number : 2938F
GSK PLC
01 March 2024
 

GSK plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 29 February 2024 consisted of 4,314,004,593 shares of 31 ¼ pence each ('Ordinary Shares'), of which 196,971,155 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,117,033,438. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Notifications may be sent to company.secretary@gsk.com.

 

 

V A Whyte

Company Secretary

 

1 March 2024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBBGDXRXGDGSB
5678910111213
Date   Source Headline
9th Dec 20214:35 pmRNSDirector/PDMR Shareholding
7th Dec 202112:00 pmRNSMedicago/GSK COVID-19 vaccine positive Ph3 data
7th Dec 20217:07 amRNSSotrovimab retains its activity vs Omicron variant
2nd Dec 20217:02 amRNSSotrovimab retains its activity vs Omicron variant
1st Dec 202111:05 amPRNTotal Voting Rights
24th Nov 20214:17 pmRNSDirector/PDMR Shareholding
24th Nov 20214:00 pmRNSGSK publishes provisional 2022 dividend dates
23rd Nov 20213:06 pmRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSNucala approved in Europe for more indications
15th Nov 20214:37 pmRNSBlock listing Interim Review
12th Nov 202112:00 pmRNSPhase III IM administration data for sotrovimab
12th Nov 20219:23 amRNSDirector/PDMR Shareholding
10th Nov 202111:28 amRNSDirector/PDMR Shareholding
5th Nov 20215:33 pmRNSGSK shares positive Phase III data for daprodustat
1st Nov 20215:11 pmRNSTotal Voting Rights
27th Oct 20212:23 pmRNSDirector/PDMR Shareholding
27th Oct 202112:00 pmRNS3rd Quarter Results
27th Oct 20219:00 amRNSDirectorate Change
15th Oct 20212:41 pmRNSDirector/PDMR Shareholding
14th Oct 20214:31 pmRNSDirector/PDMR Shareholding
14th Oct 20214:28 pmRNSDirector/PDMR Shareholding
13th Oct 20211:55 pmRNSDirector/PDMR Shareholding
12th Oct 20213:17 pmRNSDirector/PDMR Shareholding
12th Oct 20211:36 pmRNSDirector/PDMR Shareholding
12th Oct 20211:33 pmRNSDirector/PDMR Shareholding
12th Oct 20211:30 pmRNSDirector/PDMR Shareholding
12th Oct 20211:28 pmRNSDirector/PDMR Shareholding
1st Oct 202111:54 amRNSTotal Voting Rights
24th Sep 20215:28 pmRNSDirector/PDMR Shareholding
22nd Sep 20213:58 pmRNSDirector/PDMR Shareholding
20th Sep 20212:42 pmRNSDirector Declaration
13th Sep 20215:26 pmRNSDirector/PDMR Shareholding
9th Sep 20214:42 pmRNSDirector/PDMR Shareholding
7th Sep 20214:54 pmRNSDirector/PDMR Shareholding
3rd Sep 20219:32 amRNSDirector/PDMR Shareholding
1st Sep 202111:44 amRNSTotal Voting Rights
31st Aug 20217:00 amRNSSK bio & GSK start Ph3 Covid-19 vaccine trial
25th Aug 20212:01 pmRNSDirector/PDMR Shareholding
23rd Aug 20214:39 pmRNSDirector/PDMR Shareholding
13th Aug 20219:38 amRNSDirector/PDMR Shareholding - amendment
11th Aug 20212:18 pmRNSDirector/PDMR Shareholding
11th Aug 202112:34 pmRNSDirector/PDMR Shareholding
5th Aug 20219:00 amRNSBlock Listing Application
2nd Aug 20212:23 pmRNSTotal Voting Rights
28th Jul 20215:32 pmRNSDirector/PDMR Shareholding
28th Jul 202112:00 pmRNS2nd Quarter Results
26th Jul 20214:59 pmRNSDirector/PDMR Shareholding
23rd Jul 20212:32 pmRNSBoard Committee Changes
22nd Jul 20212:45 pmRNSCEO Designate of new Consumer Healthcare company
16th Jul 202112:00 pmRNSGSK announces daprodustat phase 3 headline results
5678910111213

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.